US equities
|
SPCX
$167.29
▲+5.24%
NVDA
$236.26
▲+0.99%
MU
$1,067.01
▼-0.73%
TSLA
$378.39
▲+2.10%
MSFT
$526.43
▲+1.72%
SNDK
$1,710.93
▼-0.53%
INTC
$117.08
▼-1.89%
META
$744.10
▲+2.20%
SPCX
$167.29
▲+5.24%
NVDA
$236.26
▲+0.99%
MU
$1,067.01
▼-0.73%
TSLA
$378.39
▲+2.10%
MSFT
$526.43
▲+1.72%
SNDK
$1,710.93
▼-0.53%
INTC
$117.08
▼-1.89%
META
$744.10
▲+2.20%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Novo Nordisk A/S Common Stock
(NY:
NVO
)
37.23
-0.09 (-0.25%)
Delayed Quote
Updated: 12:49 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novo Nordisk A/S Common Stock
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
99
100
Next >
Bragar Eagel & Squire, P.C. Reminds Investors of Novo, Altimmune, SelectQuote, and Spectrum that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm
August 21, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
↗
August 21, 2025
Via
Benzinga
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - NVO
August 21, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Health Canada Approves Novo’s Ozempic to Reduce Risk Of Kidney Function Decline, Cardiovascular Death
↗
August 19, 2025
Via
Stocktwits
Congressional Trading Report: Rep. Marjorie Taylor Greene Bought Over $15K In Novo Nordisk Stock
↗
August 21, 2025
Via
Benzinga
Contact Levi & Korsinsky by September 30, 2025 Deadline to Join Class Action Against Novo Nordisk A/S (NVO)
August 21, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Contact Levi & Korsinsky by September 30, 2025 Deadline to Join Class Action Against Novo Nordisk A/S (NVO)
August 21, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
The FDA Just Approved a New Use for Wegovy, and Novo Nordisk Stock is Climbing. Here's What Investors Need to Know
↗
August 21, 2025
The famous medicine continues its impressive march forward.
Via
The Motley Fool
Dow Futures Decline As Fed Minutes Point To Inflation Anxiety: WMT, META, PLTR, NVO Among Stocks To Watch
↗
August 21, 2025
Via
Stocktwits
Topics
Economy
Stocks
Under Pressure: Palantir and Viking Therapeutics Face Investor Scrutiny
August 20, 2025
The financial markets are a dynamic arena where fortunes can shift rapidly, and the past week has seen two prominent companies, Palantir Technologies Inc. (NYSE: PLTR) and Viking Therapeutics (NASDAQ:...
Via
MarketMinute
Topics
Artificial Intelligence
Corporate Wins: Intel, Palo Alto Networks, and Novo Nordisk Drive Market Optimism
August 20, 2025
In a week marked by a surge of positive corporate news, three industry giants—Intel, Palo Alto Networks, and Novo Nordisk—have delivered significant boosts to investor confidence, signaling robust...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Novo Nordisk Freezes Hiring As Wegovy Faces Copycats
↗
August 20, 2025
Novo Nordisk may pursue layoffs as its new CEO focuses on efficiency while facing intensifying obesity drug competition.
Via
Benzinga
Topics
Workforce
Contact Levi & Korsinsky by September 30, 2025 Deadline to Join Class Action Against Novo Nordisk A/S (NVO)
August 20, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Contact Levi & Korsinsky by September 30, 2025 Deadline to Join Class Action Against Novo Nordisk A/S (NVO)
August 20, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Novo Nordisk Freezes Hiring To Cut Costs, Says Report: Retail Sees Stock Surpassing $100-Mark In A Year
↗
August 20, 2025
Novo’s website currently shows multiple job openings in the U.S. and mainland China, but merely eight open positions in Denmark.
Via
Stocktwits
1 Reason to Buy NVO
↗
August 20, 2025
There's more to the company's leading product than meets the eye.
Via
The Motley Fool
Viking's 42% Plunge Splits Experts—A '$129 Strong Buy' Or 'Clearly Inferior' Drug?
↗
August 20, 2025
Viking (VKTX) stock plunged 42% after its obesity pill trial. Experts are split: some call it a $129 Strong Buy, others say it's inferior.
Via
Benzinga
Viking Therapeutics Plummets as Oral Obesity Drug Trial Raises Tolerability Concerns
August 19, 2025
San Diego, CA – Viking Therapeutics (NASDAQ: VKTX) experienced a dramatic stock decline today following the release of disappointing clinical trial results for its highly anticipated oral tablet...
Via
MarketMinute
Ozempic Gains First Approval In Canada For Kidney Disease And Cardiovascular Death Risk
↗
August 19, 2025
Health Canada approved Ozempic for type 2 diabetes patients with chronic kidney disease after positive FLOW trial results.
Via
Benzinga
UnitedHealth Vs. Novo Nordisk: Which Healthcare Giant Fits Your Portfolio?
↗
August 19, 2025
UnitedHealth is down 38.85% YTD; Novo Nordisk is down 38.59%. Yet, their underlying strategies couldn't be more distinct.
Via
Benzinga
Why Novo Nordisk Stock Popped Today
↗
August 19, 2025
For a cheap GLP-1 weight loss stock like Novo Nordisk, almost any news can help the stock pop.
Via
The Motley Fool
Class Action Filed Against Novo Nordisk A/S (NVO) - September 30, 2025 Deadline to Join - Contact Levi & Korsinsky
August 19, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Class Action Filed Against Novo Nordisk A/S (NVO) - September 30, 2025 Deadline to Join - Contact Levi & Korsinsky
August 19, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Viking Therapeutics Crashes 35% On Mixed Results For Its Weight-Loss Pill
↗
August 19, 2025
Shares lost more than a third of their value after Viking unveiled mixed results for its oral VK2735.
Via
Investor's Business Daily
3 Undervalued Healthcare Stocks You Can Buy Now and Hold Long-Term
↗
August 19, 2025
The healthcare industry is one of the laggards of 2025.
Via
The Motley Fool
GoodRx Holdings Surges 5% After Hours on Novo Nordisk Partnership for $499 Monthly Ozempic, Wegovy Access
↗
August 19, 2025
GoodRx stock rose 5.08% after it partnered with Novo Nordisk to offer Ozempic and Wegovy at a flat $499 monthly price for self-paying patients.
Via
Benzinga
Insiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift4
↗
August 18, 2025
A chip stock that recently partnered with NVIDIA. Now, a key company insider is buying over $160 million in shares, a bullish signal to investors.
Via
MarketBeat
Topics
Artificial Intelligence
Autonomous Vehicles Hit an Inflection Point; GPT-5 Is Here
↗
August 18, 2025
Motley Fool Money checks in on some stock market news.
Via
The Motley Fool
Topics
Economy
10 Health Care Stocks With Whale Alerts In Today's Session
↗
August 18, 2025
Via
Benzinga
Stocks Muted Ahead Trump-Zelenskyy Meeting, First Solar Jumps: What's Moving Markets Monday?
↗
August 18, 2025
Investor risk sentiment paused at the start of the week, as markets awaited details expected to emerge later when President Donald Trump meets with Ukrainian President Volodymyr Zelenskyy and European...
Via
Benzinga
Topics
Government
< Previous
1
2
...
30
31
32
33
34
35
36
37
38
...
99
100
Next >
